Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Respiratory disease programme for Darlington 2015-2017: a catalyst for change. Dr Basil Penney Sr. Claire Adams Darlington CCG Respiratory Leads Respiratory disease programme for Darlington 2015-2017: a catalyst for change. Landscape of health care is changing rapidly The burden of chronic disease The pursuit of value in healthcare provision New ways of working with other partners in commissioning services that meet the needs of the local population. Financial constraints Primary care will need to change Objectives are derived from assessment of the NEQOS report on COPD and NRAD report on asthma deaths Embed the concept of making every contact count in all practices and develop practice pathways for smoking cessation Encourage a culture of reviewing activity, sharing best practice and professional development across practices Commission a smoking cessation service for Darlington Guidance/support for practices to help identify ‘missing millions’ for COPD-through implementation of IT targeted searches and development of a diagnostic pathway in primary care Develop a breathlessness pathway in primary care Develop a “quality assured “ spirometry pathway in each practice Development of “an expert in inhaler technique” in every practice Help to set up processes in practice for ensuring review of patients following Asthma or COPD exacerbations Effective template working Tips on reviewing those with a diagnosis of COPD/asthma against the background of multiple co-morbidity Promotion of value based interventions eg pulmonary rehabilitation, influenza vaccination. Identification and implementation of value –based medication changes where it is safe to do so. Implementation of actions for primary care set out in National Review of Asthma Deaths Effective stepwise Asthma management (identifying possible ‘stepping down’ based on high dose ICS) Offer to provide general respiratory update to clinicians (GP and nurses) Development of agreed commissioning intentions for Darlington Barnett K et al;Lancet 2012; 380: 37–43 Why breathlessness? LTC agenda-demand v resources Co-morbidities Holistic v disease specific 14-18% of people with COPD only have COPD and when actively assessed for co-morbidities it may be as low as 3% Breathlessness is mentioned as a reason for encounter in primary care in about 1% of the recorded consultations in general practice Primary care agenda DIAGNOSTIC SPIROMETRY APRILJULY 2014 Practice Name Whinfield Orchard court Moorlands Neasham Road Carmel Blacketts Cliffton Court Denmark Street Rockliffe Court Felix House Parkgate Surgery 34 0 13 38 36 0 0 45 6 9 3 552 Diagnostic spirometry / year-data from 8 practices • Breathlessness Questionnaire-49 /79 response 3 case studies of breathlessness Under use of CXR Lack of recognition of role anxiety/depression Understanding of Guidelines Role of HCA Spirometry taking up to 6 weeks(variation) Underuse of microspirometry CONCLUSIONS: Pre-bronchodilator microspirometry seems to be able to reliably preselect patients for further assessment of airflow obstruction by means of regular diagnostic spirometry. However, use of microspirometry alone would result in overestimation of airflow obstruction and should not replace regular spirometry when diagnosing COPD in primary care. npj Primary Care Respiratory Medicine (2014) 24, 14033; doi:10.1038/npjpcrm.2014.33; Further Action Increase awareness of breathlessness Code for breathlessness Measure diagnostic activity- spirometry ; ECHO; BNP New Diagnoses COPD and HF with breathlessness code Adult Breathlessness Assessment Algorithm Breathlessness Pathway? Quality Assured Spirometry GP to GP referral? Community Clinics? Unforseen Risk!